Angelman Syndrome Treatment Being Developed is Awarded ‘Orphan Drug’ Status in the U.S.
Source: Pixabay

Angelman Syndrome Treatment Being Developed is Awarded ‘Orphan Drug’ Status in the U.S.

A new drug being developed to treat Angelman syndrome (AS) has just been approved for ‘orphan drug’ status in the U.S., reports GlobeNewswire. The drug, called GTX-101, works by activating the…

Continue Reading Angelman Syndrome Treatment Being Developed is Awarded ‘Orphan Drug’ Status in the U.S.